Piracetam
ApprovedTerminated 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Ischaemic Middle Cerebral Artery Stroke
Conditions
Acute Ischaemic Middle Cerebral Artery Stroke
Trial Timeline
Aug 1, 1998 → Jul 1, 2001
NCT ID
NCT01883011About Piracetam
Piracetam is a approved stage product being developed by UCB for Acute Ischaemic Middle Cerebral Artery Stroke. The current trial status is terminated. This product is registered under clinical trial identifier NCT01883011. Target conditions include Acute Ischaemic Middle Cerebral Artery Stroke.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00567060 | Pre-clinical | Completed |
| NCT01883011 | Approved | Terminated |
Competing Products
20 competing products in Acute Ischaemic Middle Cerebral Artery Stroke